Mahamaya Lifesc.

  • Market Cap: Micro Cap
  • Industry: Pesticides & Agrochemicals
  • ISIN: INE0U9D01019
  • NSEID:
  • BSEID: 544611
INR
173.00
0.00 (0.00%)
BSENSE

May 21

BSE+NSE Vol: 3600

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationUpcoming Result: Mahamaya Lifesc. will declare its result soon on 25 May 2026
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.6 k (-64.29%) Volume

Shareholding (Mar 2026)

FII

4.77%

Held by 4 FIIs

DII

2.52%

Held by 0 DIIs

Promoter

56.35%

Why is Mahamaya Lifesciences Ltd falling/rising?

21-May-2026

As of 20-May, Mahamaya Lifesciences Ltd's stock price has risen to 173.00, reflecting a 0.58% increase after three days of decline. However, despite today's gain, the stock has faced recent challenges with declines over the past week and month, and decreased investor participation suggests caution.

As of 20-May, Mahamaya Lifesciences Ltd is experiencing a rise in its stock price, currently at 173.00, which reflects an increase of 1.0 or 0.58%. This upward movement comes after three consecutive days of decline, indicating a potential trend reversal. Additionally, the stock has outperformed its sector by 3.36% today, suggesting a relative strength compared to other companies in the Pesticides & Agrochemicals sector, which has seen a decline of 2.78%.<BR><BR>Despite the positive movement today, it is important to note that the stock has faced challenges over the past week and month, with declines of 4.68% and 2.45%, respectively. Year-to-date, the stock is down 6.23%, although it has outperformed the benchmark Sensex, which has fallen 11.62% during the same period. The stock's current price is above its 50-day and 200-day moving averages, but below its 5-day, 20-day, and 100-day moving averages, indicating mixed signals regarding its short-term momentum.<BR><BR>Investor participation has decreased, with a delivery volume of 8.4k on 19 May, which is down 35.19% compared to the 5-day average. This decline in participation could suggest caution among investors, despite the stock's current rise. Overall, while Mahamaya Lifesciences Ltd is experiencing a rise today, the broader context shows a mixed performance with recent declines and reduced investor activity.

View full answer

Which are the latest news on Mahamaya Lifesc.?

21-May-2026
No latest news for Mahamaya Lifesc. found.

When is the next results date for Mahamaya Lifesciences Ltd?

21-May-2026

The next results date for Mahamaya Lifesciences Ltd is 25 May 2026.

The next results date for Mahamaya Lifesciences Ltd is scheduled for 25 May 2026.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pesticides & Agrochemicals

stock-summary
Market cap

INR 405 Cr (Micro Cap)

stock-summary
P/E

32.00

stock-summary
Industry P/E

30

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.09

stock-summary
Return on Equity

25.71%

stock-summary
Price to Book

8.12

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.37%
0%
-4.37%
6 Months
51.95%
0%
51.95%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Mahamaya Lifesc. for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Board Meeting Intimation for Prior Intimation Of The Board Meeting Pursuant To Regulation 29(1) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015

20-May-2026 | Source : BSE

Mahamaya Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 inter alia to consider and approve We wish to inform you that a meeting of the Board of Directors of Mahamaya Lifesciences Limited is scheduled to be held on Monday May 25 2026 interalia to consider and approve the following agenda: 1. The Audited Standalone Financial Results of the Company for the half year and financial year ended 31.03.2026 along with the Audit Report thereon. 2. The Audited Consolidated Financial Results of the Company for the half year and financial year ended 31.03.2026 along with the Audit Report thereon.

Announcement under Regulation 30 (LODR)-Monitoring Agency Report

15-May-2026 | Source : BSE

Submission of Monitoring Agency Report for the half year ended on March 31 2026

Compliances-Reg.24(A)-Annual Secretarial Compliance

05-May-2026 | Source : BSE

Non Applicability of Annual Secretarial Compliance Report for the financial year ended on 31.03.2026 under Regulation 24A of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

25 May 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
2.80
Debt to EBITDA (avg)
3.33
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
2.25
Tax Ratio
25.72%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.30%
ROCE (avg)
17.93%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
32
Industry P/E
30
Price to Book Value
8.12
EV to EBIT
20.25
EV to EBITDA
18.78
EV to Capital Employed
4.41
EV to Sales
1.73
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
21.80%
ROE (Latest)
25.71%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Sideways
KST
Dow Theory
Mildly Bearish
OBV
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 4 FIIs (4.77%)

Promoter with highest holding

Krishnamurthy Ganesan (21.86%)

Highest Public shareholder

Pink Tiger Alliances Llp (10.35%)

Individual Investors Holdings

10.65%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Mahamaya Lifesc."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "163.06",
          "val2": "146.23",
          "chgp": "11.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.58",
          "val2": "13.33",
          "chgp": "16.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.85",
          "val2": "3.55",
          "chgp": "8.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.53",
          "val2": "7.25",
          "chgp": "17.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.55%",
          "val2": "9.12%",
          "chgp": "0.43%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Mahamaya Lifesc."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 63.49% vs 17.87% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 147.89% vs 39.20% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "264.15",
          "val2": "161.57",
          "chgp": "63.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.94",
          "val2": "13.24",
          "chgp": "73.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.83",
          "val2": "5.90",
          "chgp": "15.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "12.94",
          "val2": "5.22",
          "chgp": "147.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.68%",
          "val2": "8.19%",
          "chgp": "0.49%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
163.06
146.23
11.51%
Operating Profit (PBDIT) excl Other Income
15.58
13.33
16.88%
Interest
3.85
3.55
8.45%
Exceptional Items
0.00
0.00
Standalone Net Profit
8.53
7.25
17.66%
Operating Profit Margin (Excl OI)
9.55%
9.12%
0.43%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
264.15
161.57
63.49%
Operating Profit (PBDIT) excl Other Income
22.94
13.24
73.26%
Interest
6.83
5.90
15.76%
Exceptional Items
0.00
0.00
Consolidate Net Profit
12.94
5.22
147.89%
Operating Profit Margin (Excl OI)
8.68%
8.19%
0.49%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 63.49% vs 17.87% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 147.89% vs 39.20% in Mar 2024

stock-summaryCompany CV
About Mahamaya Lifesciences Ltd stock-summary
stock-summary
Mahamaya Lifesciences Ltd
Micro Cap
Pesticides & Agrochemicals
Mahamaya Lifesciences Limited was originally incorporated as a private limited Company as "Mahamaya Life Sciences Private Limited" by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002. Further, Company's name was changed from "Mahamaya Life Sciences Private Limited" to "Mahamaya Lifesciences Private Limited" dated February 15, 2016. The status was changed to Public Limited Company on November 19, 2024 by the Central Processing Centre.
Company Coordinates stock-summary
Icon
No Company Details Available